FDA approves Merck’s Keytruda as breast cancer treatment

The Food and Drug Administration (FDA) approved Merck’s immunotherapy Keytruda for early treatment of triple-negative breast cancer (TNBC) in combination with chemotherapy, the pharmaceutical company announced on Tuesday. The federal agency’s…